U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description

Bacitracin is a polypeptide antibiotic produced by Bacillus subtilis and Bacillus licheniformis. Bacitracin in combination with neomycin and polymyxin B is indicated for the treatment of many bacterial diseases. The antibacterial properties of bacitracin are mediated by its binding to C55-isoprenyl pyrophosphate, resulting in inhibition of cell wall biosynthesis.

Originator

Approval Year

1948
85
Targets

Targets

Primary TargetPharmacologyConditionPotency
Binding Agent
907
Eye Infections, Bacterial
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
C55-isoprenyl pyrophosphate
Approved
7817
CORTISPORIN
Primary
C55-isoprenyl pyrophosphate
Approved
7817
NEOSPORIN
Primary
C55-isoprenyl pyrophosphate
Approved
7817
BACITRACIN
PubMed

PubMed

TitleDatePubMed
Detection by HPLC-ICP of metallothionein in serum of an epileptic child with valproate-associated hepatotoxicity.
1992 Dec
Differential dephosphorylation of the insulin receptor and its 160-kDa substrate (pp160) in rat adipocytes.
1992 Jul 15
Mechanisms of Zn(2+)-induced signal initiation through the epidermal growth factor receptor.
2003 Aug 15
Human peptidoglycan recognition protein-L is an N-acetylmuramoyl-L-alanine amidase.
2003 Dec 5
Differential effects of zinc on functionally distinct human growth hormone mutations.
2003 Jul
Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process.
2003 Nov 14
Zinc modulates PPARgamma signaling and activation of porcine endothelial cells.
2003 Oct
Purification of recombinant human apometallothionein-3 and reconstitution with zinc.
2003 Sep
O6-alkylguanine-DNA alkyltransferase: low pKa and high reactivity of cysteine 145.
2003 Sep 23
Heparin-binding epidermal growth factor cleavage mediates zinc-induced epidermal growth factor receptor phosphorylation.
2004 Apr
Patents

Patents

3943143
6
3959300
5
3959322
49
3965108
5
3983245
10
3989685
8
3991123
6
4039353
5
4061771
14
4080330
6
4138410
10
4147693
6
4166131
12
4166816
9
4194049
5
4234517
7
4262000
6
4262013
6
4276363
5
4307243
5
4308208
7
4331676
11
4347246
6
4374139
5
4382949
5
4400492
8
4440685
11
4443365
8
4443631
5
4481142
5
4497738
7
4497817
6
4505911
5
4515948
7
4518603
5
4525361
15
4543430
5
4544458
5
4549192
5
4568782
5
4570171
6
4622403
5
4654363
6
US2498165
5
US2834711 A
5

Sample Use Guides

In Vivo Use Guide
400 units, topically
Route of Administration: Topical
In Vitro Use Guide
The MIC value was 32 mg/L for Staphylococcus aureus wild type strain after 48h incubation at 37°C.
Name Type Language
BACITRACIN
EP   HSDB   INN   MI   ORANGE BOOK   USP   USP-RS   VANDF   WHO-DD   WHO-IP  
INN  
Official Name English
TOPITRACIN
Common Name English
LANABIOTIC COMPONENT BACITRACIN
Common Name English
BACITRACIN [WHO-IP]
Common Name English
PENITRACIN
Common Name English
MYCITRACIN COMPONENT BACITRACIN
Common Name English
FORTRACIN
Common Name English
BACITRACIN [VANDF]
Common Name English
BACIIM
Brand Name English
BACITRACIN [USP]
Common Name English
PARENTRACIN
Common Name English
BACIGUENT
Brand Name English
BACITRACIN [EP]
Common Name English
BACI-RX
Brand Name English
BACITRACIN [ORANGE BOOK]
Common Name English
BACILLIQUIN
Common Name English
BACITRACIN [WHO-DD]
Common Name English
BACITRACIN [HSDB]
Common Name English
BACITRACINUM [WHO-IP LATIN]
Common Name English
BACITRACIN COMPONENT OF MYCITRACIN
Common Name English
ZUTRACIN
Common Name English
BACITRACIN [USP-RS]
Common Name English
BACITRACIN COMPONENT OF LANABIOTIC
Common Name English
TROPITRACIN
Common Name English
BACITRACIN [JAN]
Common Name English
BACITRACIN [INN]
Common Name English
BACITRACIN(NON-INJECTABLE) [WHO-IP]
Common Name English
BACITRACIN [MI]
Common Name English
Classification Tree Code System Code
WHO-VATC QR02AB04
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
WHO-ATC J01XX10
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
CFR 21 CFR 333.120
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
CFR 21 CFR 524.155
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
WHO-ATC R02AB04
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
CFR 21 CFR 556.70
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
EPA PESTICIDE CODE 6302
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
CFR 21 CFR 333.110
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
CFR 21 CFR 524.154
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
CFR 21 CFR 520.154
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
WHO-ATC D06AX05
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
WHO-VATC QJ01XX10
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
WHO-VATC QD06AX05
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
WHO-VATC QA07AA93
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
Code System Code Type Description
WIKIPEDIA
BACITRACIN
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
PRIMARY
ECHA (EC/EINECS)
215-786-2
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
PRIMARY
EVMPD
SUB00652MIG
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
PRIMARY
RXCUI
1291
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
PRIMARY RxNorm
WHO INTERNATIONAL PHARMACOPEIA
BACITRACIN
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
PRIMARY Description: A white or pale brownish yellow powder; odourless or with a faint characteristic odour. Solubility: Freely soluble in water, methanol R and ethanol (~750 g/l) TS; practically insoluble in acetone R and ether R. Category: Antiinfective drug. Storage: Bacitracin should be kept in a tightly closed container, protected from light and stored at a temperature between 2? and8?C. If it is intended for parenteral administration, the container should be sterile and sealed so as to exclude micro-organisms. Labelling: The designation sterile Bacitracin indicates that the substance complies with the additional requirements for sterileBacitracin and may be used for parenteral administration or for other sterile applications. Additional information: Bacitracin is hygroscopic. Its solutions deteriorate rapidly at room temperature. Even in the absence oflight, it is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures.
DRUG BANK
DB00626
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
PRIMARY
NCI_THESAURUS
C295
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
PRIMARY
INN
1167
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
PRIMARY
MERCK INDEX
M2197
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
PRIMARY Merck Index
NDF-RT
N0000008479
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
PRIMARY Decreased Cell Wall Synthesis & Repair [PE]
MESH
D001414
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
PRIMARY
CAS
1405-87-4
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
PRIMARY
ChEMBL
CHEMBL1200558
Created by admin on Tue Mar 06 13:25:24 UTC 2018 , Edited by admin on Tue Mar 06 13:25:24 UTC 2018
PRIMARY
All of the following components must be present:
Structure of BACITRACIN B2
Structure of BACITRACIN B3
Structure of BACITRACIN B1
Structure of BACITRACIN A
ACTIVE MOIETY
BACITRACIN
Definition References
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966